Skip to main content
Back to companies
Atlanta, GA, USAFounded 20214+ employeesPrivate
$9M raisedSeed· last: series unknown (Oct 2025)· 5 rounds
Backed by(4 investors)

Andson Biotech built, from the ground up, process analytical technologies (PATs) to fill the void of existing sensor technologies for advanced biomanufacturing.

Founders

YC W22

Hiring Pitch

About Andson: (TL;DR video about us: https://youtu.be/wMyAikoQkXE)

Andson Biotech is developing a microfluidic platform enabling rapid sample cleanup for mass spectrometry applications. Mass spectrometry is a gold-standard chemical analysis tool, but it remains limited in utility due to the complex workflows associated with going from raw sample to analysis. Our flagship product, the DynaCHIP, enables simple, on-demand mass spectrometric analysis with easy-to-use interfaces that democratize mass spectrometry from lab to market.

Andson Biotech was spun out of Georgia Tech and is supported by Y Combinator and Merck Digital Sciences Studio. We are a seed-stage startup, so every role has the chance for growth.

Skip jobs list

Open Positions at Andson Biotech (1 Jobs)

1 open · 3 filled

Showing 1 jobs